Ming Zhou

14.9k citations

210 papers · 10.1k indexed · 5 hit papers · h-index 57

Impact in

Cancer Research top 0.1%
- Cancer-related molecular mechanisms research
- MicroRNA in disease regulation
- Cancer, Hypoxia, and Metabolism
Molecular Biology top 0.5%
- RNA modifications and cancer
- Circular RNAs in diseases
- RNA Research and Splicing
- Epigenetics and DNA Methylation

Papers in

Cancer Research 84
- Cancer-related molecular mechanisms research 53
- MicroRNA in disease regulation 18
- Cancer, Hypoxia, and Metabolism 16
Molecular Biology 131
- RNA modifications and cancer 48
- Chromatin Remodeling and Cancer 22
- Cancer-related gene regulation 16
- Circular RNAs in diseases 16
- RNA Research and Splicing 15

Co-authors: Guiyuan Li Wei Xiong Zhaoyang Zeng Bo Xiang Xiayu Li Xiaoling Li Qianjin Liao Can Guo
Journals: Journal of Cancer (7 papers)Frontiers in Oncology (7 papers)Molecular Cancer (6 papers)Oncotarget (6 papers)Cell Death and Disease (6 papers)
Partner nations: China United States Saudi Arabia

In The Last Decade

Ming Zhou

204 papers receiving 9.9k citations

Hit Papers

5 papers align trajectories log scale

New frontiers in immune checkpoint B7-H3 (CD276) research and drug development 2023 · 122 citations

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if any of the following hold:

it has ≥500 total citations;
it reaches ≥1.5× the top-1% citation threshold for papers in the same subfield and year (the threshold is the minimum needed to enter the top 1%, not the average within it);
it reaches the top citation threshold in at least one of its specific research topics.

2023 Molecular Cancer
2021 Molecular Cancer
2020 Journal of Experimental & Clinical Cancer Research
2020 Frontiers in Oncology
2018 Journal of Experimental & Clinical Cancer Research

Peers

Countries citing papers authored by Ming Zhou

Since Specialization

Citations

This map shows the geographic impact of Ming Zhou's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ming Zhou with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ming Zhou more than expected).

Fields of papers citing papers by Ming Zhou

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ming Zhou. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ming Zhou. The network helps show where Ming Zhou may publish in the future.

Co-authors

The 25 scholars most cited alongside Ming Zhou, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Ming Zhou Line = papers co-authored together Ming Zhou links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Using mpMRI, PSMA, and GRPR PET to Assess Focal Therapy Eligibility and Plan Treatment in Biopsy-proven Low-/Intermediate-risk Prostate Cancer: A Whole-mount Pathology-based Study Clinical Nuclear Medicine ·Y Li, Ding Yanli, 治正伊東, Ming Zhou, Xiaomei Gao, Axel Rominger, Kuangyu Shi, Robert Seifert, Yi Cai, Yongxiang Tang, Shuo Hu	2025	1
2	Arecoline upregulates CD155 expression to facilitate immune evasion in oral squamous cell carcinoma Journal for ImmunoTherapy of Cancer ·Qian Wang, J. C. Belsten, Yuhang Liu, Shanshan Zhang, Yian Wang, Pan Chen, Bo Xiang, Ming Zhou, Zhaojian Gong, 朽名悟, Junshang Ge, Wei Xiong	2025	0
3	A radionuclide-labeled nanomedicine for STING pathway activation- and oxygenation-augmented orthotopic cancer radioisotope-immunotherapy Chemical Engineering Journal ·Schapiro Rt, Ming Zhou, Ying Peng, Hao Lü, Ding Yanli, Peng Liu, Shuo Hu	2024	7
4	Human papillomavirus-encoded circular RNA circE7 promotes immune evasion in head and neck squamous cell carcinoma Nature Communications ·Reynaldo de Faria Brizon, J. C. Belsten, Jiayue Guo, Pan Chen, Jie Wang, Lei Shi, Dan Wang, Hongke Qu, Pan Wu, Chunmei Fan, Shanshan Zhang, Qianjin Liao, Ming Zhou, Bo Xiang, Fuyan Wang, Ming Tan, Zhaojian Gong, Wei Xiong, Zhaoyang Zeng	2024	22
5	Autophagy: a critical mechanism of N6-methyladenosine modification involved in tumor progression and therapy resistance Cell Death and Disease ·Feiyang Wang, Qianjin Liao, Charlee Millett, Jingyi Li, Qingqing Wei, Mengna Li, Hongyu Deng, Wei Xiong, Ming Tan, Ming Zhou	2024	1
6	Association of synaptic density and cognitive performance in temporal lobe epilepsy: Humans and animals PET imaging study with [¹⁸F]SynVesT‐1 Psychiatry and Clinical Neurosciences ·治正伊東, Aurelija Rudzianskaitė, 寺澤勝也, Haoyue Zhu, Ming Zhou, Yongxiang Tang, Li Feng, Shuo Hu	2024	2
7	A PET probe targeting polyamine transport system for precise tumor diagnosis and therapy Asian Journal of Pharmaceutical Sciences ·Ming Zhou, W. C. Heng, Bei Chen, Shuo Hu, Wenhu Zhou	2024	2
8	CircBRD7 attenuates tumor growth and metastasis in nasopharyngeal carcinoma via epigenetic activation of its host gene Cancer Science ·Tm L, Mengna Li, Shipeng Chen, 森滉平, Letícia Vieira Senger, Yumei Duan, Hongyu Deng, Songqing Fan, Wei Xiong, Ming Zhou	2023	6
9	The mammalian Sterile 20-like kinase 4 (MST4) signaling in tumor progression: Implications for therapy Cancer Letters ·Xiao-Yan Li, Ming Zhou, Shi‐Yuan Cheng, Ming Tan	2023	7
10	miR-1 Inhibits the Ferroptosis of Chondrocyte by Targeting CX43 and Alleviates Osteoarthritis Progression Journal of Immunology Research ·Ming Zhou, Chenjun Zhai, Kai Shen, Gang Liu, Lei Liu, Jian He, M. and B̈ottger, U. ADENITAN	2023	12
11	Characterization of the mechanism of Scutellaria baicalensis on reversing radio-resistance in colorectal cancer Translational Oncology ·Chun Chun Shu, Ming Zhou, Huan Zhang, Ye‐Ying Fang, Gang Chen, Marianne Viel, ره نج داوده	2022	10
12	Hydrogen sulfide protects against particle‐induced inflammatory response and osteolysis via SIRT1 pathway in prosthesis loosening The FASEB Journal ·Lei Liu, Ming Zhou, Наталья Сергеевна Дворянчикова, Jun Zhou, Ni Li, Zhidong Wang, Naicheng Liu, Feng Zhu, Tongguo Shi, Zhantao Deng, Yong Wang, Dennis Chun-Yu Ho, Rongqun Li, Huilin Yang, Zhenheng Wang, D. Hoffer, Yaozeng Xu	2020	21
13	Effects of tumor metabolic microenvironment on regulatory T cells Molecular Cancer ·Yian Wang, Xiaoling Li, Yongzhen Mo, Chunmei Fan, Le Tang, Fang Xiong, Can Guo, Bo Xiang, Ming Zhou, Jian Ma, Xi Huang, Xu Wu, Yong Li, Guiyuan Li, Zhaoyang Zeng, Wei Xiong	2018	143
14	Gut Microbiota Mediates the Protective Effects of Dietary Capsaicin against Chronic Low-Grade Inflammation and Associated Obesity Induced by High-Fat Diet mBio ·Chao Kang, Bin Wang, Kanakaraju Kaliannan, Xiaolan Wang, Hedong Lang, Suocheng Hui, Li Huang, Yong Zhang, Ming Zhou, Mengting Chen, Mantian Mi	2017	232
15	A prospective randomized clinical trial on intravitreous injection of Conbercept for macular edema secondary to retinal vein occlusion Ying Zhou, Ming Zhou, Haojie Liu	2016	1
16	Identification of FLOT2 as a novel target for microRNA-34a in melanoma Journal of Cancer Research and Clinical Oncology ·Rui Liu, أسعد فاضل منديل, Chengqun Luo, Henri Lubret, Xiao Zhou, Kun Xia, Xiang Chen, Ming Zhou, Peiguo Cao, Ke Cao, Jianda Zhou	2014	39
17	Analysis of risk factors for recurrence of giant cell tumor of the sacrum and mobile spine combined with preoperative embolization. PubMed ·Ming Zhou, Liang Chen, Santosh Phulare, J.R. Saah, 鲁冠球, Yiming Ji, Hsienyi Lin, Chao Chen	2013	10
18	B7-H3 Silencing Increases Paclitaxel Sensitivity by Abrogating Jak2/Stat3 Phosphorylation Molecular Cancer Therapeutics ·Kristina L. Schierhorn, Christina Tekle, Rosa León-Conejo, Alexandr Kristian, Yuhua Zhao, Ming Zhou, Zixing Liu, Yan Ding, Bin Wang, Gunhild M. Mælandsmo, Jahn M. Nesland, Øystein Fodstad, Ming Tan	2011	128
19	MicroRNA-125b Confers the Resistance of Breast Cancer Cells to Paclitaxel through Suppression of Pro-apoptotic Bcl-2 Antagonist Killer 1 (Bak1) Expression Journal of Biological Chemistry ·Ming Zhou, Zixing Liu, Yuhua Zhao, Yan Ding, Hao Liu, Yaguang Xi, Wei Xiong, Guiyuan Li, Jianrong Lu, Øystein Fodstad, Adam I. Riker, Ming Tan	2010	347
20	IONP‐PLL: a novel non‐viral vector for efficient gene delivery The Journal of Gene Medicine ·Juanjuan Xiang, Jingqun Tang, Shiguo Zhu, Xinmin Nie, D. Toro Rivandeira, Shourong Shen, Xiaoling Li, Ke Tang, Ming Zhou, M.H. Siess	2003	74

About Ming Zhou

Ming Zhou is a scholar working on Cancer Research, Molecular Biology, Oncology, Biological Psychiatry and Cell Biology, having authored 210 papers that have together received 10.1k indexed citations. Recurring topics across this work include Cancer-related molecular mechanisms research (53 papers), RNA modifications and cancer (48 papers), Chromatin Remodeling and Cancer (22 papers), MicroRNA in disease regulation (18 papers), Cancer-related gene regulation (16 papers), Cancer, Hypoxia, and Metabolism (16 papers), Circular RNAs in diseases (16 papers) and RNA Research and Splicing (15 papers). The work is most often cited by research in Cancer Research (4.6k citations), Molecular Biology (6.8k citations), Oncology (1.9k citations), Developmental Neuroscience (237 citations) and Immunology (1.1k citations). Ming Zhou has collaborated with scholars based in China, United States and Saudi Arabia. Frequent co-authors include Guiyuan Li, Wei Xiong, Zhaoyang Zeng, Bo Xiang, Xiayu Li, Xiaoling Li, Qianjin Liao, Can Guo, Yong Li and Zhaojian Gong. Their work appears in journals such as Journal of Cancer, Frontiers in Oncology, Molecular Cancer, Oncotarget and Cell Death and Disease.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact